10/19/2026
FDA seeks input on ibogaine trial design, advances psychedelic framework
FDA's request for ibogaine trial input marks a step in psychedelic drug regulation.
Topic archive
trump administration
2 stories
7/24/2026
Ibogaine may gain U.S. access under Trump administration
The Trump administration considers making ibogaine available for therapeutic use.